| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Lenalidomide | FAERS: 4 | US FAERS | |
| 2 | teriflunomide | FAERS: 4 | US FAERS | |
| 3 | MDV 3100 | FAERS: 3 | US FAERS | |
| 4 | Cabozantinib S-malate | FAERS: 2 | US FAERS | |
| 5 | Fingolimod Hydrochloride | FAERS: 2 | US FAERS | |
| 6 | Zoledronic Acid | FAERS: 2 | US FAERS | |
| 7 | Buprenorphine | FAERS: 1 | US FAERS | |
| 8 | Deferasirox | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Doxycycline | FAERS: 1 | US FAERS | |
| 10 | Everolimus | FAERS: 1 | US FAERS | |
| 11 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 12 | Latanoprost | FAERS: 1 | US FAERS | |
| 13 | N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine | FAERS: 1 | US FAERS | |
| 14 | PCI 32765 | FAERS: 1 | US FAERS | |
| 15 | Pregabalin | FAERS: 1 | US FAERS | |
| 16 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 17 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 18 | ambrisentan | FAERS: 1 | US FAERS | |
| 19 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 20 | carfilzomib | FAERS: 1 | US FAERS | |
| 21 | efavirenz | FAERS: 1 | US FAERS | |
| 22 | palbociclib | FAERS: 1 | US FAERS | |
| 23 | pomalidomide | FAERS: 1 | US FAERS | |
| 24 | ribociclib | FAERS: 1 | US FAERS | |
| 25 | Sunitinib | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.